An analyst’s call can be a major swing in momentum for a stock, creating a domino effect of revised outlooks and either buying or selling. Here are four stocks that traded with excessive volatility last Friday thanks to the notes issued by analysts; these are all calls worth noting that might not result in long-term gains.
Ahh, the excitement of Biotech Investing! Buy a company that is currently in clinical trials, wait for the data to be released, and then watch your investment go through the roof, right?
Biotech will break your heart more often than not
During the internet and telecommunications boom of the late 90’s, the concept of investment diversification in this area was nothing more than holding seven or more high technology funds. Concurrently exchange-traded funds were new and the concept of portfolio transparency was not in vogue. After the bursting of the bubble, then all of a sudden investors wanted to know more about the holdings of mutual funds. It became evident more »